Distribution skin-derived antileucoproteases SKALP marginal zone psoriatic lesion new elastase inhibitors SKALP skin-derived antileucoproteases lesional skin psoriasis present study distribution SKALP activity marginal zone psoriatic plaques zone adjacent erythemato-squamous plaques SKALP activity uninvolved skin lesion anti-elastase activity central zone plaque periphery appearance SKALP psoriatic lesion late event endothelial involvement intraepidermal accumulation PMNs epidermal proliferation abnormal keratinization observation support hypothesis induction anti-elastase activity off-switch cutaneous inflammation 